At Neotypica, we are pioneering the use of artificial intelligence to address social determinants of health (SDoH) in clinical trials. Our mission is to ensure that everyone, including underrepresented groups and emerging healthcare markets, has access to breakthrough research and life-saving innovative medicines. We provide culturally sensitive and comprehensive support to universities, foundations, and life science companies to achieve this goal.